VeriSIM Life
San Francisco
About VeriSIM Life
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2022)
- Website: verisimlife.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/verisim-life-54407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.